(Q2919537)

Statements

instance of

group or class of enzymes

1 reference

based on heuristic

inferred from molecular function

inferred from

alpha-glucosidase activity

subclass of

alpha-glucosidase

1 reference

stated in

NDF-RT

NDF-RT ID

N0000171827

retrieved

27 February 2018

has use

medication

1 reference

title

Alglucosidase alfa (English)

stated in

DrugBank

language of work or name

English

publication date

17 November 2015

DrugBank ID

01272

image

Myozyme.jpg
116 × 116; 3 KB

0 references

defined daily dose

0.1 gram

route of administration

parenteral route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=A16AB07

active ingredient in

Myozyme

1 reference

European Medicines Agency product number

EMEA/H/C/000636

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000636/human_med_000917.jsp

retrieved

22 March 2017

medical condition treated

glycogen storage disease

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

glycogen storage disease II

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

molecular function

alpha-glucosidase activity

mapping relation type

broad match

1 reference

stated in

InterPro release 2019-Nov-12

EC enzyme number

3.2.1.20

mapping relation type

broad match

1 reference

imported from Wikimedia project

German Wikipedia

has characteristic

biopharmaceutical

1 reference

title

Alglucosidase alfa (English)

stated in

DrugBank

language of work or name

English

publication date

17 November 2015

DrugBank ID

01272

Identifiers